We are live on ! Find out more
HA

HHLR Advisors Portfolio holdings

AUM $1.67B
1-Year Est. Return 7.53%
This Fund
S&P 500
This Quarter Est. Return
+21.88%
1 Year Est. Return
+7.53%
3 Year Est. Return
+82.23%
5 Year Est. Return
+55.28%
10 Year Est. Return
AUM
$4.96B
AUM Growth
+$484M
Cap. Flow
-$156M
Cap. Flow %
-3.14%
Top 10 Hldgs %
84.2%
Holding
61
New
1
Increased
4
Reduced
15
Closed
12

Top Buys

Rank Stock Value
1
PDD icon
Pinduoduo
PDD
+$335M
2
DHR icon
Danaher
DHR
+$79.7M
3
MCO icon
Moody's
MCO
+$54.2M
4
JD icon
JD.com
JD
+$25.5M
5
AMZN icon
Amazon
AMZN
+$1.39M

Top Sells

Rank Stock Value
1
DASH icon
DoorDash
DASH
+$145M
2
BABA icon
Alibaba
BABA
+$64.5M
3
DQ
Daqo New Energy
DQ
+$61.7M
4
HTHT icon
Huazhu Hotels Group
HTHT
+$53.5M
5
BBIO icon
BridgeBio Pharma
BBIO
+$41.8M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 39.04%
2 Healthcare 33.28%
3 Technology 11.06%
4 Real Estate 9.55%
5 Communication Services 4.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PDD icon
1
Pinduoduo
PDD
$124B
$1.48B 29.81%
10,110,947
+2,760,100
+38% +$335M
ONC
2
BeOne Medicines Ltd
ONC
$33.9B
$934M 18.82%
5,176,906
BEKE icon
3
KE Holdings
BEKE
$17.7B
$474M 9.55%
29,224,568
-1,440,877
-5% -$22.3M
LEGN icon
4
Legend Biotech
LEGN
$3.68B
$360M 7.26%
5,984,550
-451,983
-7% -$28.6M
MSFT icon
5
Microsoft
MSFT
$2.91T
$274M 5.53%
729,400
-72,300
-9% -$25.7M
CRM icon
6
Salesforce
CRM
$151B
$197M 3.96%
747,537
-161,100
-18% -$36.5M
TTWO icon
7
Take-Two Interactive
TTWO
$46.4B
$126M 2.54%
783,000
AMZN icon
8
Amazon
AMZN
$2.45T
$123M 2.49%
811,900
+9,900
+1% +$1.39M
DHR icon
9
Danaher
DHR
$142B
$109M 2.2%
471,100
+374,656
+388% +$79.7M
DASH icon
10
DoorDash
DASH
$85.7B
$102M 2.06%
1,032,763
-1,634,000
-61% -$145M
BABA icon
11
Alibaba
BABA
$275B
$94.6M 1.91%
1,220,618
-809,829
-40% -$64.5M
RYZB
12
DELISTED
RayzeBio, Inc. Common Stock
RYZB
$66M 1.33%
1,062,383
-333,333
-24% -$8.29M
BIDU icon
13
Baidu
BIDU
$35.5B
$63.8M 1.28%
535,400
MCO icon
14
Moody's
MCO
$84.4B
$60.9M 1.23%
+155,846
New +$54.2M
CTKB icon
15
Cytek Biosciences
CTKB
$573M
$60.7M 1.22%
6,657,030
BBIO icon
16
BridgeBio Pharma
BBIO
$16.6B
$56.2M 1.13%
1,391,240
-1,391,510
-50% -$41.8M
ENFN
17
DELISTED
Enfusion, Inc.
ENFN
$48.3M 0.97%
4,975,183
JD icon
18
JD.com
JD
$43.3B
$41.9M 0.84%
1,451,150
+941,300
+185% +$25.5M
CPNG icon
19
Coupang
CPNG
$27B
$35.9M 0.72%
2,217,800
-362,900
-14% -$5.99M
HTHT icon
20
Huazhu Hotels Group
HTHT
$13.2B
$31.3M 0.63%
935,920
-1,497,163
-62% -$53.5M
NMRA icon
21
Neumora Therapeutics
NMRA
$311M
$29M 0.58%
1,699,313
MDLZ icon
22
Mondelez International
MDLZ
$84B
$26.8M 0.54%
370,188
-71,500
-16% -$4.9M
YSG
23
Yatsen Holding
YSG
$314M
$25.6M 0.52%
6,987,840
ZTO icon
24
ZTO Express
ZTO
$18.4B
$17.3M 0.35%
814,524
-536,402
-40% -$12.2M
YMM icon
25
Full Truck Alliance
YMM
$9.85B
$15.8M 0.32%
2,252,542
-1,281,390
-36% -$9.04M

Similar funds

HHLR Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, HHLR Advisors held 61 positions worth $4.96B, up 11% from $4.48B the previous quarter. Its ten largest holdings account for 84% of the portfolio.

HHLR Advisors withdrew a net $156M in Q4 2023, closing 12 positions and reducing 15 holdings. Its most notable exit was Daqo New Energy, an estimated $61.7M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 39% of assets, up from 31% a quarter earlier, followed by Healthcare and Technology.

Against the trend, HHLR Advisors opened a new position in Moody's worth $60.9M.

  • HHLR Advisors's largest Q4 2023 buy was Moody's: 155,846 shares worth $60.9M.
  • HHLR Advisors added most to Pinduoduo in Q4 2023, an estimated $335M increase.
  • HHLR Advisors's biggest Q4 2023 reduction was DoorDash, cutting an estimated $145M.
  • HHLR Advisors fully exited Daqo New Energy in Q4 2023, selling an estimated $61.7M.
  • HHLR Advisors's ten largest holdings make up 84% of its $4.96B portfolio in Q4 2023.
  • HHLR Advisors opened 1 new position and closed 12 in Q4 2023.
  • HHLR Advisors's portfolio value rose 11% quarter-over-quarter to $4.96B.

Based on HHLR Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.